SEPTEMBER 2022LIFE SCIENCES REVIEW4LAST WORDIN MY OPINION08Dr. Linda Randall,AVP Biologics Development, Manufacturing & Control,Pharmaron Gene TherapyJesper Lekdorf,MD, Sr. Medical Director, Head of Medical Affairs, Novo Nordisk JapanThe Tipping Point for Scalable Manufacturing Processes to Pivot Gene TherapiesImprovements in insulin delivery over time and expectations for the futureLUAMEDDelivering End-to-End Toxicological EvaluationCOVER STORYTanja Zidan,CEO12CONTENTS30
< Page 3 | Page 5 >